# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-14-2024 | 06-30-2024 | 10-Q | |
2 | 05-15-2024 | 03-31-2024 | 10-Q | |
3 | 04-01-2024 | 12-31-2023 | 10-K | |
4 | 11-20-2023 | 09-30-2023 | 10-Q | |
5 | 08-25-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Edward White reiterates 60 Degrees (NASDAQ:SXTP) with a Neutral.
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW)))) ("60P" or the "Company"), a pharmaceutical company foc...
HC Wainwright & Co. analyst Edward White reiterates 60 Degrees (NASDAQ:SXTP) with a Neutral.
60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(4.23) per share. This is a 74.88 percent increase over losses of $(16.8...